HomeLENZ • NASDAQ
add
Lenz Therapeutics Inc
Previous close
$16.53
Day range
$16.21 - $17.25
Year range
$15.00 - $24.59
Market cap
417.49M USD
Avg Volume
145.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 16.09M | 27.52% |
Net income | -16.65M | -31.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -16.08M | -27.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 213.28M | 379.91% |
Total assets | 217.32M | — |
Total liabilities | 19.16M | — |
Total equity | 198.17M | — |
Shares outstanding | 25.53M | — |
Price to book | 2.13 | — |
Return on assets | -27.96% | — |
Return on capital | -32.09% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -16.65M | -31.40% |
Cash from operations | -23.94M | -87.04% |
Cash from investing | 18.00M | 300,100.00% |
Cash from financing | 171.27M | 105.90% |
Net change in cash | 165.33M | 134.93% |
Free cash flow | -10.97M | — |
About
Founded
2020
Headquarters
Website
Employees
6